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Abstract 
Background: To assess the proportion of Pakistani 
patients achieving blood pressure goal while on existing 
antihypertensive therapy and reasons for not achieving BP 
goal.  
Methods: This descriptive study was conducted in 60 
centers across 10 cities of Pakistan by simple random 
sampling. It was a national, multi-centre, non-
interventional, cross-sectional, epidemiological disease 
registry. Patients, who were ≥15 years of age, on 
antihypertensive medications for ≥4 weeks and had taken 
a dose on the day of visit, were included. Investigators 
were randomly selected from a list of physicians within a 
given geographical territory (Urban) in major cities of 
Pakistan. Approximately 58% of the physicians were 
general practitioners and 42% were specialist such as 
medical internist and cardiologist. Reasons for not 
achieving BP goal was determined by assessing different 
variables. Changes made in BP management in patients 
not at BP goal and therapeutic regimens prescribed to 
patients at BP goal were also documented. Differences in 
the profile of patients according to the attainment of BP 
goal were analyzed using bi-variate analysis. A p <0.05 
was considered significant.  
Results: Mean age of patients (n=1130) was 52.6 ± 11.9 
years. Of them 49% were females. Mean duration of HTN 
was 6.1 (±6.2) years. Of 1130 patients, 23.80% achieved BP 
goal. In patients not achieving BP goal, history of 
sedentary lifestyle (60.27%), diabetes (42.97%), and 
dyslipidemia (40.30%) were identified as risk factors. 
Coronary artery disease (21.25%) was the most common co-
morbid condition. Lack of patient understanding on 
treatment importance (47.03%) was major reason for not 
achieving BP goal. Lifestyle modification (37.74%) and 
addition of another drug (37.74%) were recommended. 
Majority of patients at BP goal received angiotensin-
converting enzyme inhibitors (36.05%). 
Conclusion: In Pakistan, only one in four patients 
taking antihypertensive medications and presenting to 
physicians achieves BP goal as per JNC VII guidelines. 
This has significantly improved as compared with 
previous survey. Lack of understanding of importance of 
BP treatment remains the major impediment in achieving 
better BP control. 
Key Words: Hypertension, Risk factors, 
Antihypertensive agents, Blood Pressure goal  
Introduction 
The National Health Survey of Pakistan reports that 
only 3% hypertensive patients in Pakistan are at blood 
pressure (BP) goal despite availability of 
antihypertensive drugs and treatment 
recommendations. During the last decade, new 
therapies have been introduced and international and 
local guidelines have been revised to set improved BP 
goals for patients. Hypertension is one of the major 
risk factors for cardiovascular and kidney diseases, 
and an important public health concern. Worldwide, 
there were 978 million adults (aged ≥25 years) who 
had uncontrolled hypertension in 2008  and this 
number is predicted to increase to 1.56 billion by 
2025.1,2 Within Asia the prevalence of hypertension is 
high, with rates of 19% in China (2002)  and 46% in 
India (2009-10).3,4 The National Health Survey of 
Pakistan (NHSP; 1990-1994) reports indicate that while 
hypertension affects 18% of adults >15 years of age 
and 33% of adults >45 years of age in Pakistan. Only 
37% of people have ever had their blood pressure (BP) 
checked and only 3% of people with hypertension 
achieve BP goal (≤140/90 mm Hg).5   
Hypertension causes high mortality, imposes huge 
economic burden, and negatively impacts the health 
related quality of life (HRQoL).6-8  Hypertension has a 
considerable psychological impact. Patients who are 
aware of their hypertension status show reduced 
physical functioning and general health scores during 
HRQoL assessment compared to patients who are 
unaware of it. 9 Hypertension plays a crucial role in the 
development of cerebrovascular disease, ischemic 
heart disease, cardiac and renal failure, and some of its 
co-morbidities aggravate its cardiovascular risk.10  Risk 
factors for hypertension include age, smoking, 
physical inactivity, overweight/obesity and a positive 
family history.11.13 Inadequately addressing these risk 
factors in hypertensive patients results in higher 
morbidity and mortality, thus, making them 
appropriate targets for management. 10,12  Evidence 
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indicates that physical activity of 30 minutes a day 
significantly reduced mean BP levels.14  
Current data suggests that most patients require more 
than one antihypertensive agent for achieving BP 
goals.15 Feldman et al. proposed a simplified 
antihypertensive algorithm which sequentially 
progresses therapy in response to the control status of 
hypertension: a) an initial low-dose, fixed-dose 
combination therapy (angiotensin-converting 
enzyme;ACE) inhibitor+diuretic combination or 
angiotensin receptor blocker [ARB]+diuretic 
combination) b) increasing combination therapy to 
highest dose, c) addition of a calcium channel blocker 
and up-titration and d) addition of a non-first-line 
antihypertensive agent.16 
Despite, the availability of clear treatment guidelines  
and efficient therapeutic modalities, large number of 
patients in many parts of the world  including Asia , do 
not achieve BP goals. 12,17-20 As per the last available 
estimates, only 6.4% of patients in Pakistan showed 
controlled BP levels (≤140/90 mm of Hg) between 
2003-05.21  
It has been posited that lack of patient understanding 
of treatment importance, non-adherence to prescribed 
medication, economic barriers, clinical inertia, 
presence of co-morbid conditions and lack of access to 
healthcare impede the achievement of BP goals.17,22,23   
Currently, there is a lack of nation-wide data from 
Pakistan on the extent of BP control in patients taking 
antihypertensive therapy. To address this need, the 
disease registry, ACTION - AChievement of Target BP 
In patients ON antihypertensive therapy, was aimed at 
documenting the proportion of patients achieving 
target BP goal (based on local and international (JNC 
VII) guidelines; <140/90 mm Hg for patients without 
diabetes and <130/80 mm Hg for patients with 
diabetes and/or chronic kidney disease (CKD) on 
existing antihypertensive therapy.24 Secondary 
objectives of the study include describing the profile of 
patients not at BP goal, identifying reasons for not 
achieving BP goal, documenting the change in existing 
antihypertensive treatment for patients not at BP goal 
and antihypertensive therapeutic categories (including 
mono and combination therapy) prescribed to patients 
at BP goal.  
 
Patients and Methods 
The study was conducted from April 2011 to August 
2011, in 60 centers across 10 cities of Pakistan by 
simple random sampling. The present study was a 
national, multi-centre, non-interventional, cross-
sectional, epidemiological disease registry that 
recorded the demographic and clinical characteristics 
of patients with hypertension and treatment practices 
of physicians. Data was recorded from each patient 
during a single visit to randomly selected, primary 
care centres of various cities in Pakistan, in a span of 
five months. This study was conducted in accordance 
with the principle and laid by the 18th Medical 
Assembly and the guidelines for Good Epidemiology 
Practice. The study was conducted in private clinics in 
Urban/major cities of Pakistan. Since ERC does not 
exist for such clinics. Administrative approval was 
taken from all investigators. Patients, who were ≥15 
years of age, on antihypertensive medications for ≥4 
weeks and had taken a dose on the day of visit, were 
included in the study. Exclusion criteria included 
newly diagnosed hypertensive patients, hypertensive 
patients not on drug therapy and refusal of consent. 
Investigators were randomly selected from a list of 
qualified physicians within a given geographical 
territory (Urban) in major cities of Pakistan. 
Approximately 58% of the physicians were general 
practitioners and 42% were specialists such as medical 
internist and cardiologist.  
Data was recorded on the case report form by the 
physician for 16 variables, which included 
demographic characteristics, BP control status, general 
profile, existing risk factors and co-morbid conditions 
of patients according to the attainment of BP goal. A 
history of physician-diagnosed diabetes mellitus (DM), 
coronary artery disease (CAD) congestive heart failure 
(CHF) and peripheral artery disease (PAD) was noted 
from the patient’s history based interview at the time 
of visit. DM was defined as fasting plasma glucose 
>126 mg/dl.45 CAD was defined as any measurable 
coronary atherosclerosis in a non-dilated or non-
bypassed coronary artery. CHF was defined as a 
clinical syndrome due to heart disease and 
characterized by breathlessness and abnormal sodium 
and water retention resulting in edema. 46 PAD was 
diagnosed by history of positive intermittent 
claudication or an ABI index < 0.9. Reasons for not 
achieving BP goal was determined by providing the 
investigator with the following options in the protocol: 
1)lack of access to health care, 2) non-adherence to 
treatment, 3) lack of understanding on importance of 
treatment, 4) real or perceived adverse effect, 5) 
presence of depression, 6) economic barriers to 
treatment, 7) comorbid medical condition, 8) 
inadequate therapies especially in presence of risk 
factors, 9) addition of another drugs and 10) an open 
option of ‘others’ to identify any other reason not 
listed amongst these ten. Changes made in BP 
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management in patients not at BP goal and therapeutic 
regimens prescribed to patients at BP goal were also 
documented. 
Based on a previous study from Pakistan, 18% of 
population had hypertension and only <3% of them 
had controlled BP.5 For an absolute precision of ±1% at 
95% confidence level, a sample size of 1118 was 
required. Accounting for incomplete forms, ineligible 
patients etc., a sample size of 1200 patients was 
determined. Continuous variables were reported as 
means with standard deviations. Skewed data was 
presented as median. Differences in the profile of 
patients according to the attainment of BP goal were 
analyzed using bi-variate analysis. A p <0.05 was 
considered significant.  
 
Results 
A total of 2400 patients were screened to enrol 1197 
patients who matched the eligibility criteria, of these 
only 1130 patients were evaluable. Data of 67 patients 
could not be analysed due to missing information on 
2nd reading of systolic blood pressure (SBP) / diastolic 
blood pressure (DBP) in 26 patients, chronic kidney 
disease (CKD) status in 39, age in 1 and diabetes status 
in 1.  
There was an almost equal distribution of males 
(51.00%) and females (49.00%) in the study population 
with a mean age of 52.68 (±11.86) years (Table 1). The 
mean SBP and DBP recorded in the study population 
were 145.9 (±21.90) and 91.25 (±12.60) mm Hg, 
respectively. Around 23.80% (n=269) patients achieved 
the BP goal and 76.19% (n=861) did not achieve the BP 
goal. Majority of patients at BP goal (90.33%, n=243) 
did not have either diabetes or CKD compared to 
54.35% (n=468) of patients who were not at BP goal 
(Table 2).The mean age of the patients who were not at 
BP goal was 53.10 (±11.74) years with a mean duration 
of 6.25 (±6.28) years of hypertension. Obesity (BMI 
≥30.0) was observed in 36.00% (n=310) of patients not 
at BP goal. In majority of patients not at BP goal, risk 
factors such as sedentary lifestyle (60.27%, n=519), 
history of (both type1 and type 2) diabetes (42.97%, 
n=370) and dyslipidaemia (40.30%, n=347) was 
assessed on patient’s history based interview on the 
study visit. Patients not at BP goal had 21.25% (n=183) 
prevalence of coronary artery disease (CAD) and a 
significantly higher prevalence of congestive heart 
failure (CHF) (p<0.01), peripheral artery disease 
(p<0.01), history of transient ischemic attack (p=0.01), 
and CKD (p<0.01) (Table 3).Physicians identified lack 
of understanding of the importance of treatment 
(47.03%), and non-adherence to treatment (34.49%) as 
important reasons for patients not achieving BP goal. 
Among these patients, 73.51% (n=633) were suggested 
changes in hypertension management. Lifestyle 
modifications (37.74%), addition of another drug 
(37.74%) and increase in dose of drug (21.37%) were 
the most common changes suggested (Table 4). 
 
Table 1: Demographic and clinical 
characteristics of hypertensive patients (n=1130) 
Parameters Values 
Age (years), mean ± S.D 52.68 ± 11.86 
Age at diagnosis (years);mean ± S.D 45.79 ± 11.72 
Duration of hypertension (years)  6.13 ± 6.21 
Weight (kg), mean ± S.D 74.76 ± 14.67 
Height (cm), mean ± S.D 160.23 ± 13.57 
Gender 
Male 576 (51.00) 
Female 554 (49.00) 
BMI 
Overweight (25.0 – 29.9 (kg/m2) 396 (35.04) 
Obesity (≥ 30.0 kg/m2) 394 (34.86) 
Waist circumference 
Males ≥ 90 cm 382/576 (66.31) 
Females ≥ 80 cm 434/554 (78.33) 
Waist hip ratio 
Male >0.90 436/576 (75.69) 
Female >0.80  484/554 (87.36) 
BMI=Body mass index;Values are expressed as n (%) for gender, 
BMI, waist circumference and waist hip ratio. 
Table 2: Distribution of patients by blood 
pressure control status (n=1130) 
Groups 
At BP goal 
(n=269)  
n (%) 
Not at BP goal 
(n=861)  
n (%) 
Non-diabetic, 
non CKD 
SBP<140 and 
DBP<90 
243 (90.33) 
SBP≥140 & DBP≥90 
468 (54.35) 
Either diabetic 
or CKD  
or both 
SBP≥130 and 
DBP≥80 
26 (9.66) 
SBP≥130 and 
DBP≥80 
393 (45.64) 
BP=Blood pressure, SBP=Systolic blood pressure, DBP=Diastolic 
blood pressure, CKD=Chronic kidney disease 
 
Antihypertensive therapeutic classes such as ACE 
inhibitors (36.05%), beta blockers (34.57%), calcium 
channel blockers (31.59%) and ARBs (27.88%) were the 
most common ones prescribed to patients at BP goal. 
Monotherapy was prescribed to 54.64% and 
polytherapy to 45.35%  of patients at BP goal (Table 5). 
Combination therapy included, ACE inhibitors+beta 
blockers (7.43%), ACE inhibitors+calcium channel 
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blockers (4.46%) and beta blockers+calcium channel 
blockers (3.71%) (Table 5).  
Table 3: Profile of patients by attainment of 
blood pressure goal (n=1130) 
Parameters 
At BP goal 
(n=269) 
Not at BP 
goal (n=861) 
p-
value 
Age (years), mean ± SD 51.34±12.16 53.10±11.74 0.03 
Duration of hypertension 
(years), mean ± SD 
5.72±5.99 6.25±6.28 0.22 
BMI 
Overweight (25.0-29.9 
(kg/m2) 
110 (40.89) 286 (33.21) 
 
Obese (≥ 30.0 kg/m2)   81 (30.11) 310 (36.00) 0.10 
Waist circumference 
Male ≥ 90 (cm) 
100/148 
(67.56) 
282/428 
(65.88) 
0.71 
Female ≥ 80 (cm) 
97/121 
(80.16) 
337/433 
(77.82) 
0.58 
Presence of truncal 
obesity  
   
≥ 0.90 – Males 
104/148 
(70.27) 
332/428 
(77.57) 
0.07 
≥ 0.80 – Females 
112/121 
(92.56) 
372/433 
(85.91) 
0.05 
Existing risk factors 
Sedentary life style 129 (47.95) 519 (60.27) 0.002 
Diabetes 26 (9.66) 370 (42.97) <0.01 
Dyslipidemia 96 (35.68) 347 (40.30) 0.23 
Family history of premature CVD in first degree relative 
<65 years in males 57 (21.18) 234 (27.17) <0.01 
<55 years in females 38 (14.12) 158 (18.35) 0.03 
Smoking 56 (20.81) 181 (21.02) 0.86 
History of co-morbid conditions 
Coronary artery disease 68 (25.27) 183 (21.25) 0.14 
Myocardial infarction 30 (11.15) 70 (8.13) 0.007 
Congestive heart failure 6 (2.23) 69 (8.01) <0.01 
Transient ischemic attack 15 (5.57) 50 (5.80) 0.01 
Peripheral artery disease 2 (0.74) 44 (5.11) <0.01 
Chronic kidney disease 3 (1.11) 43 (4.99) <0.01 
BP=Blood pressure, BMI=Body mass index, CVD=Cardio vascular 
disease; Values are expressed as n (%) except for age and waist 
circumference. 
 
Discussion 
Most of the studies in the developing countries 
including Pakistan have shown very poor BP control.44 
Present study shows significant improvement in 
overall control of blood pressure as compared to 
previous studies (NHSP, 1990-94). There could be 
several factors resulting in better control of BP 
including, higher literacy rates in urban population, 
better awareness campaigns by the professional 
societies, better clinic follow ups,  availability of 
cheaper generic antihypertensive drugs and 
exponential increase in print and electronic media  
Table 4: Reasons for not achieving blood 
pressure goal and changes  made in patient 
management (n=861) 
 No (%) 
Reasons for not achieving BP goal 
Lack of understanding on 
importance of treatment 
405 (47.03) 
Non-adherence to treatment 297 (34.49) 
Presence of depression 197 (22.88) 
Economic barriers to treatment 191 (22.18) 
Lack of access to health care 190 (22.06) 
Presence of co-morbid medical 
conditions 
168 (19.51) 
Inadequate therapy specially in 
presence of risk factors 
149 (17.30) 
Addition of another drug 
(NSAIDs, OCPs, TZDs) 
Interacting with antihypertensives 
61 (7.08) 
Real or perceived adverse effects 45 (5.22) 
Changes of hypertension management 
Lifestyle modification 325 (37.74) 
Add another drug 325 (37.74) 
Increase dose 184 (21.37) 
Switch medication to combo 146 (16.95) 
Switch medication to another 
monotherapy 
75 (8.71) 
Others 17 (1.97) 
BP=Blood pressure, NSAIDs=Non-steroid anti-inflammatory 
drugs, OCPs=Oral contraceptive pills, TZDs=Thiazolidinediones 
Table 5: Anti-hypertensive therapeutic classes 
and medications prescribed to patients at blood 
pressure goal and not at goal (n=1130) 
Drugs 
AT BP 
GOAL 
N=269 (%) 
 
Not AT BP 
GOAL 
N=861 (%) 
 
p-
value 
 
AT BP GOAL 
MEAN (SD) 
DURATION 
(MONTHS) 
 
NOT AT BP 
GOAL 
MEAN (SD) 
DURATION 
(MONTHS) 
Mean 
differe
nce 
p-
valu
e 
ACEI 97  (36.0) 277 (32.2) 0.237 20.8 (25.9) 17.12 (30.7) 3.6 0.559 
BB 93   (34.6) 206 (23.9) <0.01 22.8 (31.5) 24.0 (39.1) -1.17 0.871 
CCB 85  (31.6) 222 (25.8) 0.06 29.24 (46.5) 28.4 (48.4) 0.892 0.931 
ARB 75   (27.8) 161 (18.7) <0.01 21.8 (31.3) 17.7 (32.4) 4.161 0.583 
DIURETIC 39   (14.5) 116 (18.1) 0.670 16.8 (19.3) 17.9 (35.5) -1.03 0.923 
FDC 22 (8.17) 105 (12.2) 0.069 28.1 (64.8) 3.0 (3.7) 25.1 0.025 
AB 4     (1.5) 16 (1.9) 0.687 3.0 (0.0) 7.3 (11.3) -4.1 0.742 
Others 15 (5.57) 27 (3.1) 0.065 24.3 (42.5) 31.7(58.2) -7.4 0.744 
AB=Alpha Blockers, ACEI=Angiotensin Converting Enzyme 
Inhibitor, ARBs=Angiotensin Receptor Blockers, BB=Beta Blocker 
CCB=Calcium Channel Blockers, FDC=Fixed-Dose Combination  
 
showing programs on consequences of hypertension 
over last few years. Although there still remains 
significant gap in control and appropriate treatment 
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options offered to patients especially in rural 
population where most of the factors mentioned above 
are lacking. 
Patients not at BP goal had significantly higher rates of 
sedentary lifestyles, diabetes, and family history of 
premature cardiovascular disease. The most common 
co-morbid conditions in patients not at BP goal were 
CAD, previous incidence of myocardial infarction (MI) 
and CHF. Lack of patient understanding of the 
importance of treatment and non-adherence to 
prescribed medication were the important reasons 
cited by physicians for patients’ inability to achieve BP 
goal. ACE inhibitors, beta blockers and calcium 
channel blockers, both as monotherapy and 
combination (2-drug) therapy, were prescribed more 
often by physicians to patients at BP goal.  
There have been variable reports of hypertension 
management and control in Pakistan, with the 
estimates of patients who had their BP under control 
ranging from <3% (NHSP, 1990-1994) to 6.4% (2003-
2005).5,21   In our study, however, 23.8% of patients 
(n=1130) during a single visit to primary care center 
reported to have achieved a predefined BP goal. The 
difference in estimates could be due to the larger 
sample size used in the current study and 
improvement in BP control over time. It could also be 
due to a difference in study populations assessed, 
where NHSP was a population based household 
survey conducted over 4 years, while our study 
population included patients making a single visit to 
their general practitioners in urban Pakistan. 
Awareness campaigns by national and international 
societies on BP control may have contributed to some 
extent on better control .According to a data brief 
published by US center for Disease Control and 
Prevention’s National center for Health Statistics , 
about 47% of Americans with hypertension did not 
have BP under control. 43 Risk factors such as 
dyslipidemia, smoking, age, ethnicity, obesity and 
family history of premature CVD are known to elevate 
BP levels an association confirmed by a previous study 
from Pakistan. 21,25,27 
Prevalence of diabetes was found to be significantly 
more in patients who did not achieve the BP goal than 
those who did (p<0.01). Diabetes and hypertension 
have common underlying risk factors and are, in turn, 
common risk factors for both micro and macro 
vascular complications that lead to target-organ 
failure.28 It is established from previous studies 
conducted in Pakistan, that hypertension is a risk 
factor for cardiovascular morbidity and mortality.21,29 . 
In long-standing hypertension and/or diabetes, co-
morbid conditions such as CAD, MI, stroke, CHF, 
peripheral vascular disease and CKD are well 
recognized in patients. 28 In the current study 
population where the mean duration of hypertension 
was 6.3 years (not at BP goal) and 5.7 years (at BP 
goal), patients not at BP goal had significantly higher 
prevalence of macrovascular complications such as 
CHF, transient ischemic attack, periphery artery 
disease. Hypertension is known to initiate end-stage 
renal disease and is associated with rapid progression 
of CKD in patients with both hypertension and 
diabetes. 30-32  The observed prevalence of CKD (a 
microvascular complication) in the present study is in 
agreement with previous reports.  
Studies from Indian sub-continent and Western 
countries demonstrate simple treatment modalities for 
hypertension control.14,16  Studies from Pakistan and 
Spain have highlighted issues related to patient’s 
medication adherence ,  and social and financial 
barriers that are known to impede the achievement of 
BP goal, and lead to poor health outcomes in patients 
with hypertension. 22,33-35 Most physicians in the 
current study reported that patients’ lack of 
understanding of the importance of treatment was the 
single biggest reason why BP goals were not being 
achieved. Hashmi et al. found that lack of 
understanding of the effectiveness of medication was 
responsible for reduced treatment adherence.22 
Consequently, the rate of non-adherence to treatment 
(34.5%), observed in current study, is higher (23%) 
than that reported by Hashmi et al.; Almas et al. 
reported a rate of 43% in a Pakistani sample 
population with hypertension.36 Lack of access to 
healthcare reported in the study population might be a 
result of poor services at primary healthcare systems 
in rural areas, as indicated by some studies done in 
low-income countries.34 Economic barriers to BP 
control are observed in urban men from developed 
countries too.35 In addition, failure to achieve BP goals 
is also associated with clinical inertia in intensifying or 
initiating antihypertensive therapy.17 
Among the therapeutic categories prescribed to 
patients achieving BP goal, majority (54.6%) of patients 
were on monotherapy. Recent studies from Pakistan 
and India reported low rate of prescription of 
monotherapy (41% each). 15,37  Overall ACE inhibitors, 
beta blockers, calcium channel blockers and ARBs are 
the most prescribed drugs for the management of 
hypertension in Pakistan both according to the current 
study and previous reports.15 This is in line with the 
recommendations about the antihypertensive drug 
classes to be used in the management of co-morbid 
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conditions.17  Both American Diabetes Association and 
Seventh Report of Joint National Committee on 
Hypertension recommend ACE inhibitors or ARBs as 
first line therapy in hypertension with diabetes. 17, 38 
This current study reports only 27.9% patients on ARB 
therapy; a low rate of usage compared to other Asian 
studies ,  and recommendations . 17,25,37,38 The current 
study reports only 18.7% of uncontrolled patients who 
were prescribed ARBs.  
A prudent strategy that incorporating combination of 
pharmacological and non-pharmacological 
interventions is necessary to control BP. Education and 
awareness of risks of poor BP control will significantly 
improve the compliance to antihypertensive 
medications and hence the BP control. Lifestyle 
modifications are the first line treatment for patients 
with hypertension and diabetes. Regular physical 
activity of moderate intensity is known to reduce BP 
levels in patients with hypertension.14,39Treatment 
intensification (medication change or dose increase) is 
found to be associated with BP improvement in 
patients with hypertension.40 Therapeutic strategies 
like addition of another drug, increase in dose and 
change in medication recommended by physicians in 
the current study to patients not at BP goal, are in 
agreement with global practices.41  In patients unable 
to achieve the BP goal, intensification of therapy must 
be complemented by measures to improve adherence. 
Even a small reduction in the mean BP of a population 
will produce a large reduction in the incidence of 
complications.42 
Although the present study collected data on real life 
clinical practice and observations reported by 
physicians in urban Pakistan, accurate definition of 
study population and correlation to entire population 
of Pakistan may not possible. Since the study is a clinic 
based cross-sectional study carried out during a single 
visit, an indication of sequence of events and/or 
narrowing on causes of inability to control BP cannot 
be inferred accurately.  
Conclusions 
1. A low proportion of patients (23.8%), are achieving 
blood pressure goals in urban Pakistan according to 
JNC VII and local guidelines.  
2. Control of blood pressure was much lower (6.2%) in 
patients with diabetes and/or CKD.  
3.The major impediments in poor blood pressure goal 
achievement remains the lack of understanding of 
importance of blood pressure treatment and poor 
compliance which is in line with other national and 
international studies. 
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